Genmab | GEN - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 143.56M 12.5M 2026-06
Amgen USD 13.99B 1.95B 2026-06
argenx SE USD 4.3B 808.71M 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Demant DKK 1.33B 188M 2025-12
Exelixis USD 281.45M 55.3M 2026-06
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Genmab DKK 1.5B 18M 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 865M 254M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Insmed USD 544.76M 37.42M 2026-06
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 7.62B 739M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
UCB EUR 1.57B 1.14B 2024-12